RxDoctor Payments Data

Michael Pelster, MD

MOHS-Micrographic Surgery · Nashville, TNNPI 1699017145

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.7% of the total across 428 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,490, 2.2 times the $1,127 reported in 2019.

$9,663in general payments, 2019–2025

Across 428 payments — averaging $22.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$1K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Incyte Corporation$669
  • Sun Pharmaceutical Industries Inc.$505
  • Lilly USA, LLC$436
  • plus $4K from 30 others

What the payments were for

  • Food & beverage$9,15395%
  • Education$5115%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,663 in reported general payments places this provider in the 80th percentile of 40 mohs-micrographic surgery providers in Tennessee.

See all mohs-micrographic surgery providers in Tennessee

Medicare billing

Part B allowed, 2024
$450,494
Medicare patients
813
Services billed
3,520

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab13$47,683
Clobetasol Propionate100$3,835
Tacrolimus14$2,364
Doxycycline Hyclate167$2,316
Ketoconazole115$2,066
Triamcinolone Acetonide104$1,280
Desonide13$782
Clindamycin Phosphate25$746
Gentamicin Sulfate14$538
ValacyclovirValacyclovir Hcl12$251
Pregabalin12$248
Mupirocin27$169
Prednisone14$136
Hydroxyzine Hcl13$75
Cephalexin37$67

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →